Properties (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Sandoz's_generic_business_in_the_US
|
| gptkbp:awards |
various industry recognitions
|
| gptkbp:CEO |
gptkb:N._Govindarajan
|
| gptkbp:clinicalTrials |
ongoing
|
| gptkbp:collaborations |
academic institutions
research organizations |
| gptkbp:culturalHeritage |
product portfolio
geographic presence |
| gptkbp:employees |
over 20,000
|
| gptkbp:financialPerformance |
volatile
consistent growth |
| gptkbp:founded |
1986
|
| gptkbp:founder |
gptkb:K._Nityananda_Reddy
|
| gptkbp:future_plans |
quality assurance
regulatory compliance risk management cost management supply chain management market expansion long-term vision innovation focus |
| gptkbp:global_presence |
over 150 countries
|
| gptkbp:governance |
strong practices
|
| gptkbp:headquarters |
gptkb:Hyderabad,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aurobindo Pharma
|
| gptkbp:investmentFocus |
transparent communication
|
| gptkbp:market |
global
significant |
| gptkbp:partnerships |
various global pharmaceutical companies
|
| gptkbp:patentCitation |
numerous granted patents
|
| gptkbp:productionLocation |
gptkb:United_States
Europe multiple_locations_in_India |
| gptkbp:products |
active pharmaceutical ingredients
generic pharmaceuticals |
| gptkbp:research_areas |
diabetes
neurology oncology antibiotics dermatology pain management antiretrovirals gastroenterology cardiovascular respiratory |
| gptkbp:researchAndDevelopment |
strong focus
|
| gptkbp:revenue |
over $1 billion
|
| gptkbp:social_responsibility |
environmental initiatives
education initiatives healthcare_initiatives |
| gptkbp:stockExchange |
gptkb:BSE
NSE |
| gptkbp:sustainability_initiatives |
community engagement
employee welfare environmental responsibility |